Free Trial

DocGo Inc. (NASDAQ:DCGO) Receives Average Recommendation of "Buy" from Brokerages

DocGo logo with Medical background

DocGo Inc. (NASDAQ:DCGO - Get Free Report) has been assigned an average rating of "Buy" from the five analysts that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1 year price target among brokers that have issued a report on the stock in the last year is $6.10.

DCGO has been the subject of several analyst reports. Needham & Company LLC restated a "buy" rating and set a $7.00 price target on shares of DocGo in a research report on Thursday, August 8th. Cantor Fitzgerald reiterated an "overweight" rating and set a $5.00 target price on shares of DocGo in a report on Friday, September 20th.

Get Our Latest Analysis on DCGO

Institutional Trading of DocGo

A number of institutional investors and hedge funds have recently bought and sold shares of DCGO. nVerses Capital LLC increased its holdings in shares of DocGo by 151.5% in the 2nd quarter. nVerses Capital LLC now owns 8,300 shares of the company's stock worth $26,000 after buying an additional 5,000 shares during the last quarter. Gladius Capital Management LP purchased a new stake in shares of DocGo in the 2nd quarter worth approximately $34,000. Nisa Investment Advisors LLC lifted its position in shares of DocGo by 693.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company's stock worth $37,000 after purchasing an additional 10,565 shares during the period. SG Americas Securities LLC purchased a new stake in DocGo during the second quarter valued at approximately $60,000. Finally, Victory Capital Management Inc. lifted its position in DocGo by 124.0% during the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company's stock valued at $79,000 after acquiring an additional 14,191 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors.

DocGo Price Performance

Shares of NASDAQ DCGO traded up $0.09 during midday trading on Tuesday, reaching $3.47. The company's stock had a trading volume of 812,659 shares, compared to its average volume of 1,009,196. DocGo has a 12-month low of $2.75 and a 12-month high of $6.90. The firm has a 50 day moving average price of $3.45 and a 200-day moving average price of $3.32. The stock has a market capitalization of $355.05 million, a P/E ratio of 12.07, a PEG ratio of 3.10 and a beta of 0.89.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). The company had revenue of $164.95 million for the quarter, compared to analysts' expectations of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. On average, equities analysts predict that DocGo will post 0.23 EPS for the current year.

DocGo Company Profile

(Get Free Report

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Recommended Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

→ Bill Gates’s Next Big AI Bet: Stargate (From Brownstone Research) (Ad)

Should you invest $1,000 in DocGo right now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines